Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib (INNOVATE)

Clinical Trial ID NCT02786342

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02786342

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 54.30
2 VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. Int J Cancer 2014 1.11
Next 100